The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by La Cava, A.
Right arrow Articles by Sarvetnick, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by La Cava, A.
Right arrow Articles by Sarvetnick, N.
The Journal of Immunology, 2001, 167: 1066-1071.
Copyright © 2001 by The American Association of Immunologists

H-2D End Confers Dominant Protection from IL-10-Mediated Acceleration of Autoimmune Diabetes in the Nonobese Diabetic Mouse1

Antonio La Cava2, Balaji Balasa2,3, Augusta Good, Kurt van Gunst, Nadja Jung and Nora Sarvetnick4

Department of Immunology, The Scripps Research Institute, La Jolla, CA 92037

BALB/c mice that express IL-10 as a transgene in their pancreatic {beta} cells (Ins-IL-10 mice) do not develop diabetes, even after crossing to nonobese diabetic (NOD) mice ((Ins-IL-10 x NOD)F1 mice). However, backcross of F1 mice to NOD mice (NOD.Ins-IL-10 mice) results in N2 and N3 generations that develop accelerated diabetes. In this study, we found that NOD.Ins-IL-10 mice that expressed BALB/c-derived MHC molecules (NOD.Ins-IL-10(H-2g7/d) mice) were protected from diabetes. This protection associated with peri-islet infiltration and preserved {beta} cell function. Moreover, expression of I-Ad and I-Ed MHC class II molecules of BALB/c origin was not responsible for protection, but NOD.Ins-IL-10 mice that expressed BALB/c MHC class I Dd molecules (NOD.Ins-IL-10(H-2g7/d) mice) did not develop diabetes. To directly test the possibility of a protective role of H-2Dd in the development of accelerated diabetes, we generated transgenic mice expressing Dd under the control of the MHC class I promoter. We found that double transgenic NOD.Ins-IL-10-Dd mice developed accelerated diabetes in a fashion similar to NOD.Ins-IL-10 mice that were Dd negative. Microsatellite analysis of H-2Dd-linked loci confirmed association between BALB/c-derived alleles and protection of NOD.Ins-IL-10(H-2g7/d) mice. These results suggest a control of H-2Dd-linked gene(s) on IL-10-mediated acceleration of autoimmune diabetes and dominant protection of the Dd region in NOD.Ins-IL-10 mice.




This article has been cited by other articles:


Home page
J. Immunol.Home page
A. Ueno, S. Cho, L. Cheng, Z. Wang, B. Wang, and Y. Yang
Diabetes Resistance/Susceptibility in T Cells of Nonobese Diabetic Mice Conferred by MHC and MHC-Linked Genes
J. Immunol., October 15, 2005; 175(8): 5240 - 5247.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. Zhang, K. Fujio, Y. Jiang, J. Zhao, N. Tada, K. Sudo, H. Tsurui, K. Nakamura, K. Yamamoto, H. Nishimura, et al.
Dissection of the role of MHC class II A and E genes in autoimmune susceptibility in murine lupus models with intragenic recombination
PNAS, September 21, 2004; 101(38): 13838 - 13843.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.